 |
| Join us for the 2016 Executive Vision Forum |
|
| October 12, 2016 |
|
Boston Public Library | Boston, MA
4:00 pm - 10:00 pm |
|
|
 |
|
|
Share perspectives. Gather insights.
Join the discussion. |
|
| Flow of the day: |
|
4:00 pm - 4:45 pm
Networking Reception
|
|
4:45 pm - 5:00 pm
Welcome/Introduction
|
|
5:00 pm - 5:30 pm
Quintiles POV
|
|
5:30 pm - 6:30 pm
Keynote Presentation/Q&A
|
|
6:30 pm - 6:45 pm
Break
|
|
6:45 pm - 7:45 pm
Dinner
|
|
7:45 pm - 8:30 pm
Panel Discussion
|
|
8:30 pm - 8:45 pm
Q&A and Closing Remarks
|
|
8:45 pm - 10:00 pm
Post-event Reception
|
|
| This year's Executive Vision Forum will explore how biopharma can connect the comprehensive perspective, design and understanding of human behavior to the data, processes and analytics required to connect insights from pipeline to portfolio to population health. |
|
| To learn more about the Executive Vision Forum visit our website. |
|
|
|
|
|
|
| Keynote speaker |
|
 |
|
| Dr. Mark McClellan |
|
| Director, Duke-Margolis Center for Health Policy |
|
| Mark McClellan, MD, PhD is the Robert J. Margolis Professor of Business, |
|
| Medicine, and Policy, and director of the Duke-Margolis Center for Health Policy at Duke University. |
|
| McClellan is a doctor and an economist, and his work has addressed a wide range of strategies and policy reforms to improve health care, including such areas as payment reform to promote better outcomes and lower costs, methods for development and use of real-world evidence, and more effective drugs and devices. |
|
|
| Panel discussion |
|
| Who will benefit from evidence?: This session will focus on how evidence will help drive decisions in oncology drug development and commercialization by outlining better ways to identify patients, design protocols and the understanding of value and competition fundamental to the future of medicine. |
|
| Panelists: |
|
 |
|
Art Small
Director & Therapeutic Area Head, Oncology Outcomes Research, US Medical Affairs, Genentech, Inc.
|
|
 |
|
Bernard Munos
Senior Fellow, Faster Cures, a center of the Milken Institute
|
|
 |
|
C. Randal Mills, Ph.D.
President & CEO, California Institute for Regenerative Medicine
|
|
 |
|
Murray Aitken
Senior Vice President, IMS Health
|
|
|
|
Moderator: John Doyle, Senior Vice
President, Quintiles Advisory Services
|
|
| For questions, please contact: amber.frasketi@quintiles.com or 919.998.7648 |
|
 |
|
|
